Use of dienogest in endometriosis. A narrative literature review and expert commentary
Objective: Endometriosis affects up to 10% of women of reproductive age, and the main goal of treatment is to relieve symptoms. Progestins have been the mainstay of endometriosis suppression, of which dienogest has become an important option in many parts of the world. This is an expert literature r...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House TRILIST
2020-05-01
|
Series: | Репродуктивная эндокринология |
Subjects: | |
Online Access: | http://reproduct-endo.com/article/view/202609 |
id |
doaj-beb9cd2cd02644de91d08fd4598a1cf5 |
---|---|
record_format |
Article |
spelling |
doaj-beb9cd2cd02644de91d08fd4598a1cf52021-07-02T10:47:24ZengPublishing House TRILISTРепродуктивная эндокринология2309-41172411-12952020-05-01052738110.18370/2309-4117.2020.52.73-81202609Use of dienogest in endometriosis. A narrative literature review and expert commentaryAlly Murji0Kutay Biberoğlu1Jinhua Leng2Mount Sinai Hospital, University of TorontoAnkara Private IVF CenterPeking Union Medical College HospitalObjective: Endometriosis affects up to 10% of women of reproductive age, and the main goal of treatment is to relieve symptoms. Progestins have been the mainstay of endometriosis suppression, of which dienogest has become an important option in many parts of the world. This is an expert literature review, with recommendations on the use of dienogest in the context of various clinical considerations when treating endometriosis. Methods: A search of PubMed was conducted for papers published between 2007 and 2019 on the use of dienogest in endometriosis. Experts reviewed these and included those they considered most relevant in clinical practice, according to their own clinical experience. Results: Evidence regarding the long-term use (>15 months) of dienogest for the management of endometriosis is presented, with experts concluding that the efficacy of dienogest should be assessed primarily on its impact on pain and quality of life. Fertility preservation, the option to avoid or delay surgery, and managing bleeding irregularities that can occur with this treatment are also considered. Counseling women on potential bleeding risks before starting treatment may be helpful, and evidence suggests that few women discontinue treatment for this reason, with the benefits of treatment outweighing any impact of bleeding irregularities. Conclusions: Overall, the evidence demonstrates that dienogest offers an effective and tolerable alternative or adjunct to surgery and provides many advantages over combined hormonal contraceptives for the treatment of endometriosis. It is important that treatment guidelines are followed and care is tailored to the woman’s individual needs and desires.http://reproduct-endo.com/article/view/202609endometriosishormoneprogestinexpertsreview |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ally Murji Kutay Biberoğlu Jinhua Leng |
spellingShingle |
Ally Murji Kutay Biberoğlu Jinhua Leng Use of dienogest in endometriosis. A narrative literature review and expert commentary Репродуктивная эндокринология endometriosis hormone progestin experts review |
author_facet |
Ally Murji Kutay Biberoğlu Jinhua Leng |
author_sort |
Ally Murji |
title |
Use of dienogest in endometriosis. A narrative literature review and expert commentary |
title_short |
Use of dienogest in endometriosis. A narrative literature review and expert commentary |
title_full |
Use of dienogest in endometriosis. A narrative literature review and expert commentary |
title_fullStr |
Use of dienogest in endometriosis. A narrative literature review and expert commentary |
title_full_unstemmed |
Use of dienogest in endometriosis. A narrative literature review and expert commentary |
title_sort |
use of dienogest in endometriosis. a narrative literature review and expert commentary |
publisher |
Publishing House TRILIST |
series |
Репродуктивная эндокринология |
issn |
2309-4117 2411-1295 |
publishDate |
2020-05-01 |
description |
Objective: Endometriosis affects up to 10% of women of reproductive age, and the main goal of treatment is to relieve symptoms. Progestins have been the mainstay of endometriosis suppression, of which dienogest has become an important option in many parts of the world. This is an expert literature review, with recommendations on the use of dienogest in the context of various clinical considerations when treating endometriosis.
Methods: A search of PubMed was conducted for papers published between 2007 and 2019 on the use of dienogest in endometriosis. Experts reviewed these and included those they considered most relevant in clinical practice, according to their own clinical experience.
Results: Evidence regarding the long-term use (>15 months) of dienogest for the management of endometriosis is presented, with experts concluding that the efficacy of dienogest should be assessed primarily on its impact on pain and quality of life. Fertility preservation, the option to avoid or delay surgery, and managing bleeding irregularities that can occur with this treatment are also considered. Counseling women on potential bleeding risks before starting treatment may be helpful, and evidence suggests that few women discontinue treatment for this reason, with the benefits of treatment outweighing any impact of bleeding irregularities.
Conclusions: Overall, the evidence demonstrates that dienogest offers an effective and tolerable alternative or adjunct to surgery and provides many advantages over combined hormonal contraceptives for the treatment of endometriosis. It is important that treatment guidelines are followed and care is tailored to the woman’s individual needs and desires. |
topic |
endometriosis hormone progestin experts review |
url |
http://reproduct-endo.com/article/view/202609 |
work_keys_str_mv |
AT allymurji useofdienogestinendometriosisanarrativeliteraturereviewandexpertcommentary AT kutaybiberoglu useofdienogestinendometriosisanarrativeliteraturereviewandexpertcommentary AT jinhualeng useofdienogestinendometriosisanarrativeliteraturereviewandexpertcommentary |
_version_ |
1721331715776970752 |